Abstract
ABSTRACT Objective: The objective of the study was to determine the clinical features, treatment received, and outcomes of severely ill children with multisystem inflammatory syndrome in children (MIS-C). Methods: The study was a retrospective observation carried out at a pediatric intensive care unit in a tertiary care hospital. The baseline history, investigations, treatment received, and outcomes of the disease in 14 critically ill children, who were diagnosed with MIS-C, were surveyed from October 2020 to January 2022. Results: There were 14 children who were diagnosed with MIS-C. All children received intensive care treatment and 7 children received a combination of steroid therapy and intravenous immunoglobulin. Out of 14 children, 12 of them survived and 2 expired. Conclusion: For children who are diagnosed with MIS-C, the outcome was good if detected early and treated on time.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
